Exane Derivatives Iqvia Holdings Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Iqvia Holdings Inc. stock. As of the latest transaction made, Exane Derivatives holds 490 shares of IQV stock, worth $102,488. This represents 0.07% of its overall portfolio holdings.
Number of Shares
490
Previous 490
-0.0%
Holding current value
$102,488
Previous $113,000
6.19%
% of portfolio
0.07%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding IQV
# of Institutions
1,120Shares Held
155MCall Options Held
227KPut Options Held
1.16M-
Vanguard Group Inc Valley Forge, PA20.3MShares$4.24 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY15.2MShares$3.19 Billion0.07% of portfolio
-
Harris Associates L P Chicago, IL10.7MShares$2.23 Billion3.9% of portfolio
-
State Street Corp Boston, MA8.03MShares$1.68 Billion0.08% of portfolio
-
Geode Capital Management, LLC Boston, MA4.22MShares$883 Million0.08% of portfolio
About IQVIA HOLDINGS INC.
- Ticker IQV
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 185,740,000
- Market Cap $38.8B
- Description
- IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...